Trial
NCT05435014
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
Phase ISUSPENDEDREGULATORYConfidence: HIGH
Sponsor
T-ACE Medical Co., Ltd
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
T-ACE Oil
Why stopped
The study was suspended in Taiwan following regulatory authority decision. The overall study under U.S. IND remains active.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-14